PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportssecondary hyperparathyroidism
MeSH D006962 - secondary hyperparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006961:Hyperparathyroidism
32 Companies
4 Drugs
$
Success rate
D006962: 
Secondary hyperparathyroidism
16 Companies
2 Drugs
$
Success rate
D012080:Chronic kidney disease-mineral and bone disorder
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareCinacalcet Cinacalcet  2020-05-15   
Cinacalcet Cinacalcet Accordpharma  2020-04-03   
Alkem LaboratoriesCinacalcet Cinacalcet  2019-05-17   
AllerganCinacalcet Cinacalcet  2018-12-27   
AmgenCinacalcet Mimpara  2004-10-22   
Etelcalcetide Parsabiv  2016-11-11   
Cinacalcet Sensipar 2026-09-22 2004-03-08   
Aurobindo PharmaCinacalcet Cinacalcet  2018-03-08   
Chartwell PharmaceuticalsCinacalcet Cinacalcet  2020-05-18   
CiplaCinacalcet Cinacalcet  2018-03-08   
Dr Reddys LaboratoriesCinacalcet Cinacalcet  2020-09-18   
HeteroCinacalcet Cinacalcet  2020-10-07   
Jerome Stevens PharmaceuticalsCinacalcet Cinacalcet  2021-12-02   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
100%
12/12
Phase 3
86%
12/14
Approved: 3Overall Success rate: 86%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amgen
Etelcalcetide,
Cinacalcet,
Benzocaine,
Alfacalcidol,
Sodium chloride,
Sodium lactate,
Velcalcetide,
Microcrystalline cellulose,
Retinol
KAI Pharmaceuticals
Etelcalcetide,
Benzocaine,
Velcalcetide
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use